TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
148,040
|
131,408
|
61,826 |
Financial expenses |
2
|
7
|
4 |
Earnings before taxes |
25,958
|
26,060
|
-1,124 |
EBITDA |
30,060
|
29,090
|
731 |
Total assets |
108,905
|
83,338
|
41,059 |
Current assets |
79,307
|
49,861
|
26,778 |
Current liabilities |
39,058
|
35,339
|
15,667 |
Equity capital |
68,418
|
47,999
|
25,392 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
4
|
3
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.8%
|
57.6%
|
61.8% |
Turnover per employee |
37,010
|
43,803 | |
Profit as a percentage of turnover |
17.5%
|
19.8%
|
-1.8% |
Return on assets (ROA) |
23.8%
|
31.3%
|
-2.7% |
Current ratio |
203.0%
|
141.1%
|
170.9% |
Return on equity (ROE) |
37.9%
|
54.3%
|
-4.4% |
Change turnover |
16,632
|
69,582
|
8,935 |
Change turnover % |
13%
|
113%
|
17% |
Chg. No. of employees |
1
|
3
|
0 |
Chg. No. of employees % | 33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.